论文部分内容阅读
为确定一些新疗法如肝移植和抗病毒治疗的应用指征。本文对98例组织学证实为HBsAg阳性肝硬化患者的生存情况进行分析。材料和方法:1970年1月～1990年6月,作者共收治450例慢性乙肝病毒感染的患者。其中98例肝活检诊断为肝硬化,77例为代偿期,21例为失代偿期。分析随访初爱试者的性别、年龄、自觉症状、饮酒、腹水、脑病、食管静脉曲张、HBeAg状态以及AST、胆红素、白蛋白和凝血因子,以确定其在预后存活期的意义。平均随访期为4.3年(0.1～18年)。
To determine the application of some new therapies such as liver transplantation and antiviral therapy. In this paper, 98 cases of histologically confirmed survival of patients with HBsAg-positive cirrhosis were analyzed. Materials and Methods: From January 1970 to June 1990, a total of 450 patients with chronic hepatitis B virus infection were treated. Among them, 98 cases of liver biopsy were diagnosed as cirrhosis, 77 cases were decompensated and 21 cases were decompensated. The sex, age, symptoms, drinking, ascites, encephalopathy, esophageal varices, HBeAg status, AST, bilirubin, albumin and clotting factors were analyzed to determine their significance in the prognosis of follow-up. The average follow-up period was 4.3 years (0.1-1.18 years).